BackAfterNext HealthTech Acquisition Overview

AfterNext HealthTech Acquisition EBIT

Track AfterNext HealthTech Acquisition's EBIT ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

$0.00

As of Mar 31, 2023

Annual EBIT (TTM)

$0.00

Trailing 12 months ending Mar 31, 2023

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

AfterNext HealthTech Acquisition (AFTR) FAQ

AfterNext HealthTech Acquisition posts a EBIT of $0 as of March 2023. That is above the sector sector average of $-77M. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

For its sector stocks, a EBIT near $-77M is typical. AfterNext HealthTech Acquisition's $0 is higher that level. That is roughly 100.0% above the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

EBIT is one piece of AfterNext HealthTech Acquisition's financial statement story. At $0, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for AFTR's EBIT usually means three checks: (1) trend versus prior periods, (2) level versus peers (average $-77M), and (3) consistency with growth and profitability. This page covers the first two; AfterNext HealthTech Acquisition's other metric pages and overview cover the third.